News

Climate friendly and efficient use of inhalers – from aerosol inhalers to powder-based inhalers

Published on: 16/11/2023

Climate friendly and efficient use of inhalers – from aerosol inhalers to powder-based inhalers
A new project in the Region of Southern Denmark will investigate which patients can safely switch to a more climate friendly inhaler.
Denmark
Green Health, Sustainability
Ecosystems

From January 2024, a new project in the Region of Southern Denmark will investigate which patients suffering from lung conditions can safely switch to a more climate friendly powder-based inhaler instead of an aerosol inhaler. 

 

Up to 25% of the greenhouse gasses coming from the Danish hospitals can be linked to the use of medicine. 3% of this amount is solely related to the use of aerosol inhalers (pMDI) that contain hydrofluorocarbons (HFC). Therefore, the use of aerosol inhalers has a significantly higher climate impact than the powder inhalers (DPI) as the latter does not use HFC gasses.

 

The purpose of the project is to investigate which patients suffering from lung conditions can switch to more climate friendly powder-based inhalers (Dry Powder Inhaler, DPI) instead of aerosol inhalers (Pressurised Metered- Dose Inhaler, pMDI) in a safe manner and without compromising their treatment and health.  

 

By changing the type of inhalers, the healthcare sector would be able to contribute significantly to the sustainability agenda as DPI inhalers emit significantly less greenhouse gasses than pMDI inhalers. 

 

The project will collect and analyse historic data on the health status of patients who have switched from aerosol inhalers to powder-based inhalers. These analyses will serve as the foundation for identifying which patients and with which characteristics can potentially switch to powder-based inhalers with no consequences for their treatment or health status. Furthermore, the project will investigate the user perspective and potential barriers for patients and health care professionals in relation to the switch. 

 

The results of the project will serve as the foundation for regional recommendations for implementing processes for switching patients from aerosol- to powder inhalers in a safe manner across the entire region. 

 

The project is led by the Department of Pharmacology at Odense University Hospital, who are in charge of sustainable medicine in the Region of Southern Denmark, in close collaboration with the Health Innovation Centre of Southern Denmark. GSK, Hospital Pharmacy, and the Lung Association are network partners in the project. 

 

If you want to know more, please contact Caroline Strudwick, Project Manager at the Health Innovation Centre of Southern Denmark at Caroline.Strudwick@rsyd.dkCaroline.Strudwick@rsyd.dk

 

NEWS​

Related News

New Round Tables announced to drive progress on EHDS and health AI

3 Jul 2025

The European Accessibility Act Is Here. Are You Ready?

2 Jul 2025
Why inclusive design is no longer optional – and how Big Motive can help you lead the way.

DTH-Lab Director: The G7 must act now to address the digital health transformation

2 Jul 2025
As digital platforms increasingly shape health systems and information flows, the G7 must lead in setting global standards to ensure safety, equity an...

InnoHSupport Open Calls

1 Jul 2025
Welcome to the InnoHSupport Open Calls!

Transformative Health Instrument Call 2025

1 Jul 2025
Apply to the Transformative Health Instrument (THI) Call 2025 if you are a growing and innovative healthcare start-up working on solutions that have s...

Longitude Prize on ALS

1 Jul 2025
The £7.5 million (~$10 million) Longitude Prize on ALS incentivises the use of AI-based approaches to transform drug discovery for amyotrophic lateral...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *